Добірка наукової літератури з теми "GFAP biomarker"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "GFAP biomarker".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "GFAP biomarker"
Huss, André, Ahmed Abdelhak, Benjamin Mayer, Hayrettin Tumani, Hans-Peter Müller, Katharina Althaus, Jan Kassubek, et al. "Association of Serum GFAP with Functional and Neurocognitive Outcome in Sporadic Small Vessel Disease." Biomedicines 10, no. 8 (August 2, 2022): 1869. http://dx.doi.org/10.3390/biomedicines10081869.
Повний текст джерелаHögel, Heidi, Eero Rissanen, Christian Barro, Markus Matilainen, Marjo Nylund, Jens Kuhle, and Laura Airas. "Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity." Multiple Sclerosis Journal 26, no. 2 (December 20, 2018): 210–19. http://dx.doi.org/10.1177/1352458518819380.
Повний текст джерелаBustamante, Alejandro, Anna Penalba, Cyrille Orset, Leire Azurmendi, Víctor Llombart, Alba Simats, Emili Pecharroman, et al. "Blood Biomarkers to Differentiate Ischemic and Hemorrhagic Strokes." Neurology 96, no. 15 (March 5, 2021): e1928-e1939. http://dx.doi.org/10.1212/wnl.0000000000011742.
Повний текст джерелаHalford, Julia, Sean Shen, Kyohei Itamura, Jaclynn Levine, Albert C. Chong, Gregg Czerwieniec, Thomas C. Glenn, et al. "New astroglial injury-defined biomarkers for neurotrauma assessment." Journal of Cerebral Blood Flow & Metabolism 37, no. 10 (August 17, 2017): 3278–99. http://dx.doi.org/10.1177/0271678x17724681.
Повний текст джерелаBorko, Tyler L., Britney Barrera, Christopher Mizenko, Aurélie Ledreux, Ryan Kammeyer, Alanna Ritchie, Sean Selva, et al. "Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls." Neurology 99, no. 23 Supplement 2 (December 5, 2022): S8—S9. http://dx.doi.org/10.1212/01.wnl.0000903096.36040.1d.
Повний текст джерелаGanne, Akshatha, Meenakshisundaram Balasubramaniam, W. Sue T. Griffin, Robert J. Shmookler Reis, and Srinivas Ayyadevara. "Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease." Pharmaceutics 14, no. 7 (June 26, 2022): 1354. http://dx.doi.org/10.3390/pharmaceutics14071354.
Повний текст джерелаZwirner, Johann, Simone Bohnert, Heike Franke, Jack Garland, Niels Hammer, Dustin Möbius, Rexson Tse, and Benjamin Ondruschka. "Assessing Protein Biomarkers to Detect Lethal Acute Traumatic Brain Injuries in Cerebrospinal Fluid." Biomolecules 11, no. 11 (October 25, 2021): 1577. http://dx.doi.org/10.3390/biom11111577.
Повний текст джерелаSavage, William J., Zongming Fu, Emily Barron-Casella, Pratima Dulloor, Jacky Jennings, Elizabeth Dackiw, Kimberly Jones, et al. "Glial Fibrillary Acidic Protein as a Plasma Biomarker of Brain Injury in Children with Sickle Cell Disease." Blood 114, no. 22 (November 20, 2009): 1512. http://dx.doi.org/10.1182/blood.v114.22.1512.1512.
Повний текст джерелаChaykovskaya, A. D., M. P. Topuzova, A. M. Makhanova, A. G. Mikheeva, D. S. Korotkova, M. L. Pospelova, E. B. Panina, et al. "Role of neuron-specific enolase, glial fibrillar acidic protein and NR2-antibodies in early diagnostic of ischemic stroke." Translational Medicine 8, no. 5 (December 18, 2021): 5–20. http://dx.doi.org/10.18705/2311-4495-2021-8-5-5-20.
Повний текст джерелаEbenau, Jarith L., Wiesje Pelkmans, Inge M. W. Verberk, Sander C. J. Verfaillie, Karlijn A. van den Bosch, Mardou van Leeuwenstijn, Lyduine E. Collij, et al. "Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline." Neurology 98, no. 13 (February 2, 2022): e1315-e1326. http://dx.doi.org/10.1212/wnl.0000000000200035.
Повний текст джерелаДисертації з теми "GFAP biomarker"
Wiegmann, Tim [Verfasser], Hendrik [Gutachter] Milting, and Christos [Gutachter] Krogias. "Nutzen von GFAP und S100B als prädiktiver Biomarker für neurologische Komplikationen bei Patienten mit einem Herzunterstützungssystem / Tim Wiegmann ; Gutachter: Hendrik Milting, Christos Krogias." Bochum : Ruhr-Universität Bochum, 2016. http://d-nb.info/1123283230/34.
Повний текст джерелаHoller, Alicia Leanne. "Functional 3-D Cellulose and Nitrocellulose Paper-based, Microfluidic Device Utilizing ELISA Technology for the Detection/Distinction Between Hemorrhagic and Ischemic Strokes." DigitalCommons@CalPoly, 2016. https://digitalcommons.calpoly.edu/theses/1707.
Повний текст джерелаTrautz, Florian. "Überlebenszeitabhängige Änderungen der zerebralen IL-6- und GFAP-Expression nach letalen Schädel-Hirn-Traumen." 2020. https://ul.qucosa.de/id/qucosa%3A73840.
Повний текст джерелаRawji, Khalil S. "A Comparative Analysis of the Neurochemical Properties of Olfactory Ensheathing Cells and their Biocompatibility in Various Biomatrices." Thesis, 2012. http://hdl.handle.net/1974/7335.
Повний текст джерелаThesis (Master, Neuroscience Studies) -- Queen's University, 2012-07-27 15:29:47.642
Chang, Shiou-Ming, and 張修明. "Characterization of the activation of a GFP expression system driven by p21Cip1/Waf1promoter as a biomarker of cellular senescence in mammalian cells." Thesis, 2005. http://ndltd.ncl.edu.tw/handle/03292468454478382947.
Повний текст джерела國立屏東科技大學
生物科技研究所
93
Advances in medicine and public health resulted in a large increase in the average life span of humans, whereas aging of the population is also getting more and more obvious. Therefore, how to maintain a healthy, quality life in the old age of an individual has become an important issue. The purpose of this study is to establish a cell-based screening system which not only can be applied to the screening of anti-aging reagents from large amounts of samples, but also can be a tool for the study of molecular mechanism of cellular senescence. However, the prerequisite for the efficiency of this system is to develop a method that can readily detect the aging of cell in vivo.Cellular senescence was defined as the irreversible arrest of cells in the G1 phase of cell cycle. Study of the molecular mechanism of cellular senescence showed that p21cip1/waf1 is highly expressed in aged cells. p21cip1/waf1 was demonstrated to induce the arrest of cell cycle in G1 phase, resulting in entry of cell into the senescence state. In this project, various lengths of DNA fragments were subcloned from the p21cip1/waf1 promoter region of human genomic DNA, and ligated into the upstream of the gene of green fluorescent protein (GFP) in an expression vector. The vector was then stably transfected into BHK-21 cells, a baby hamster kidney normal cell line. The expression level of GFP was then be analyzed by fluorescent microscope and flow cytometer. The data demonstrated that induction of the aging of transfected BHK-21 cell was accompanied by the elevated expression of GFP. In addition, whether different regions of the p21cip1/waf1 promoter play important roles in the process of cellular aging was characterized as well.
Частини книг з теми "GFAP biomarker"
Abdi, Fahmida, Ann M. Simpson, Sara Lal, and Kaneez Fatima Shad. "Early Predictive Biomarkers for Hypertension Using Human Fetal Astrocytes." In Erythrocyte - A Peripheral Biomarker For Infection and Inflammation. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.98561.
Повний текст джерелаPapa, Linda. "Acute Assessment of Mild Traumatic Brain Injury." In Neurotrauma, edited by John K. Yue, Ethan A. Winkler, Hansen Deng, Amy J. Markowitz, Kevin K. W. Wang, and Geoffrey T. Manley, 101–10. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190279431.003.0009.
Повний текст джерела"), confocal laser scanning microscopy (Eberl et al. 1997) or enumerated by flow cytometry (Tombolini et al. 1997). A further advantage of GFP, over other biomarkers, is the fact that no other energy source or substrate addition is required, other than oxygen during initial formation of the chromophore. Therefore, the GFP biomarker holds tremendous promise for elucidation of specific bacterial numbers and their behaviour, colonization, distribution, interaction, and movement in situ in a diversity of environmental sample types. Additionally, mutations have been introduced into the GFP gene in order to produce fluorescence signals with altered properties (Heim et al. 1994, Delagrave et al. 1995, Crameri et 1996, Heim and Tsien 1996). For example, one of the mutants (P4) is a." In Recent Advances in Marine Biotechnology, Vol. 8, 237. CRC Press, 2003. http://dx.doi.org/10.1201/9781482279986-29.
Повний текст джерела"or phenotype to enable monitoring in a given environment (Jansson and De Bruijn 1999). These biomarkers therefore fill a surrogate role, supplying an assayable gene product when an assay for a gene product of interest is not available or is very difficult to perform. Two biomarkers which have become extremely attractive for monitoring microbial communities and activity are the genes encoding luciferase enzymes and the green fluorescent protein (GFP). This is mainly due to their ease of use, along with the ability to perform the assays in a nondestructive manner. Such non destructive assays allow for repeated experiments to be performed on the same sample, and so changes of a microbial community can be observed." In Recent Advances in Marine Biotechnology, Vol. 8, 234–35. CRC Press, 2003. http://dx.doi.org/10.1201/9781482279986-27.
Повний текст джерелаТези доповідей конференцій з теми "GFAP biomarker"
Ciesielski, Michael J., Phillip Galbo, Sheila Figel, Laura Wiltsie, Cheryl Frank, Jingxin Qiu, and Robert A. Fenstermaker. "Abstract 2725: Circulating CD9-GFAP-survivin exosomes during active specific immunotherapy, a potential biomarker for glioma." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-2725.
Повний текст джерелаRocha, Andreia, Bruna Bellaver, Luiza Machado, Carolina Soares, Pâmela C. L. Ferreira, Samuel Greggio Gianina T. Venturin, Jaderson C. da Costa, Diogo O. Souza, and Eduardo R. Zimmer. "TEMPORAL CHANGES IN ASTROCYTES ON A TRANSGENIC RAT MODEL OF AD." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda023.
Повний текст джерелаPorter, Jason, Adriana Hepner, Manjari Pandey, Philippe Prouet, Felicia Hare, Syed S. Nasir, Madison Boles, Henrik Zetterberg, Kaj Blennow, and Michael Martin. "Abstract 1352: Serum neurofilament light (NfL), glial fibrillary acidic protein (GFAp) and tau protein are possible serum biomarkers for activity of brain metastases and gliomas." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-1352.
Повний текст джерелаPorter, Jason, Adriana Hepner, Manjari Pandey, Philippe Prouet, Felicia Hare, Syed S. Nasir, Madison Boles, Henrik Zetterberg, Kaj Blennow, and Michael Martin. "Abstract 1352: Serum neurofilament light (NfL), glial fibrillary acidic protein (GFAp) and tau protein are possible serum biomarkers for activity of brain metastases and gliomas." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-1352.
Повний текст джерела